These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 6300370)
1. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity. Wiersma DA; Roth RA J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370 [TBL] [Abstract][Full Text] [Related]
2. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data. Wiersma DA; Roth RA Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365 [TBL] [Abstract][Full Text] [Related]
3. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung. Wiersma DA; Roth RA J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of nicotine on benzo(a)pyrene elimination and marked pulmonary metabolism of nicotine in isolated perfused rat lung. Foth H; Rüdell U; Ritter G; Kahl GF Klin Wochenschr; 1988; 66 Suppl 11():98-104. PubMed ID: 3184783 [TBL] [Abstract][Full Text] [Related]
5. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol. Reinke LA; McManus P; Kauffman FC; Thurman RG Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282 [TBL] [Abstract][Full Text] [Related]
6. The fate of intratracheally installed benzo(a)pyrene in the isolated perfused rat lung of both control and 20-methylcholanthrene pretreated rats. Vainio H; Uotila P; Hartiala J; Pelkonen O Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):259-71. PubMed ID: 1257613 [TBL] [Abstract][Full Text] [Related]
7. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition. Roth RA Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197 [TBL] [Abstract][Full Text] [Related]
8. Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei. Alexandrov K; Thompson MH Cancer Res; 1977 May; 37(5):1443-9. PubMed ID: 856463 [TBL] [Abstract][Full Text] [Related]
9. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver. Kari FW; Kauffman FC; Thurman RG Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167 [TBL] [Abstract][Full Text] [Related]
10. Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration. Foth H; Mollière M; Kahl R; Jähnchen E; Kahl GF Drug Metab Dispos; 1984; 12(6):760-6. PubMed ID: 6150827 [TBL] [Abstract][Full Text] [Related]
11. Binding of benzo(a)pyrene and dibenz(a,h)anthracene to the Ah receptor in mouse and rat hepatic cytosols. Okey AB; Dubé AW; Vella LM Cancer Res; 1984 Apr; 44(4):1426-32. PubMed ID: 6322977 [TBL] [Abstract][Full Text] [Related]
12. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes. Hara E; Kawajiri K; Tagashira Y Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488 [TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin A deficiency on pulmonary and hepatic in vitro metabolism of benzo(a)pyrene in rat. Dogra SC; Khanduja KL; Sharma RR; Hom T; Varanasi U Biochem Int; 1985 Dec; 11(6):869-84. PubMed ID: 3937530 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of benzo[a]pyrene by the isolated perfused rabbit lung. Smith BR; Philpot RM; Bend JR Drug Metab Dispos; 1978; 6(4):425-31. PubMed ID: 28923 [TBL] [Abstract][Full Text] [Related]
15. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver. Kari FW; Kauffman FC; Thurman RG Cancer Res; 1985 Apr; 45(4):1621-7. PubMed ID: 3978630 [TBL] [Abstract][Full Text] [Related]
16. The influence of flow on the metabolism of perfused benzo[a]pyrene by isolated rat lung. Wiersma DA; Braselton WE; Roth RA Chem Biol Interact; 1983 Jan; 43(1):1-15. PubMed ID: 6295648 [TBL] [Abstract][Full Text] [Related]
17. Influence of red blood cells, serum albumin, and serum lipoproteins on the clearance of benzo[alpha]pyrene by isolated livers of 3-methylcholanthrene-treated rats. Wiersma DA; Stemmer PM; Roth RA Biochem Pharmacol; 1984 Nov; 33(21):3433-8. PubMed ID: 6497903 [TBL] [Abstract][Full Text] [Related]
18. Programming of rat hepatic arylhydrocarbon hydroxylase activity during late neonatal period. Simpson VJ; Chung LW Proc West Pharmacol Soc; 1982; 25():257-61. PubMed ID: 6289340 [No Abstract] [Full Text] [Related]
19. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance. Wiersma DA; Roth RA J Pharmacol Exp Ther; 1980 Jan; 212(1):97-102. PubMed ID: 7351629 [TBL] [Abstract][Full Text] [Related]
20. Modulation of rat liver aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity by nutritional effects. Salazar I; Litvak S; Gil L J Toxicol Environ Health; 1983; 11(4-6):519-33. PubMed ID: 6312060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]